Stanley-Laman Group’s MaxLinear MXL Stock Holding History

Stanley-Laman Group’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,609	Closed	-$272K	–	298
2021 Q4	$272K	Buy	+3,609	New	+$231K	0.03%	243

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stanley-Laman Group's MXL Position: Q1 2022 in Review

Stanley-Laman Group sold out of MaxLinear (MXL) in Q1 2022, closing a stake of 3,609 shares — an estimated $272K sold.

Stanley-Laman Group first reported a position in MXL in Q4 2021 and held it in 1 quarter. The position peaked at $272K in Q4 2021. 293 funds tracked by Wall St. Rank hold MXL as of Q1 2022.

Stanley-Laman Group reported no remaining MaxLinear position as of Q1 2022 after selling out during the quarter.
Stanley-Laman Group sold 3,609 MaxLinear shares in Q1 2022, an estimated $272K.
Stanley-Laman Group first reported a position in MaxLinear in Q4 2021 and held it in 1 quarter.
Stanley-Laman Group's MaxLinear position peaked at $272K in Q4 2021.
293 funds tracked by Wall St. Rank held MaxLinear as of Q1 2022.

Based on Stanley-Laman Group's 13F filing for Q1 2022, filed 21 Apr 2022.